KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) Gross Profit (2017 - 2025)

Historic Gross Profit for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $3.4 million.

  • Bionano Genomics' Gross Profit rose 13990.05% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year increase of 230400.67%. This contributed to the annual value of $380000.0 for FY2024, which is 9602.76% down from last year.
  • According to the latest figures from Q3 2025, Bionano Genomics' Gross Profit is $3.4 million, which was up 13990.05% from $3.5 million recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Gross Profit registered a high of $3.5 million during Q2 2025, and its lowest value of -$8.4 million during Q3 2024.
  • Its 5-year average for Gross Profit is $1.6 million, with a median of $2.1 million in 2023.
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 65523.01% in 2022, then tumbled by 40723.9% in 2024.
  • Bionano Genomics' Gross Profit (Quarter) stood at $239000.0 in 2021, then surged by 655.23% to $1.8 million in 2022, then surged by 35.07% to $2.4 million in 2023, then soared by 40.16% to $3.4 million in 2024, then decreased by 1.38% to $3.4 million in 2025.
  • Its last three reported values are $3.4 million in Q3 2025, $3.5 million for Q2 2025, and $2.9 million during Q1 2025.